Skip to main content
NCBI home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1956 Sep;11(3):339–345. doi: 10.1111/j.1476-5381.1956.tb01078.x

Some actions of chlorpromazine

R W Ryall
PMCID: PMC1509615  PMID: 13364213

Full text

PDF
339

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARNES J. M. The effect of dinitro-o-cresol on the deposition of liver glycogen in the rat. Biochem J. 1953 Apr;54(1):148–153. doi: 10.1042/bj0540148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BRADLEY P. B., HANCE A. J. The effect of chlorpromazine on the electrical activity of the brain of the conscious cat. J Physiol. 1955 Sep 28;129(3):50–1P. doi: 10.1113/jphysiol.1955.sp005387. [DOI] [PubMed] [Google Scholar]
  3. BURN J. H. The pharmacology of chlorpromazine and promethazine. Proc R Soc Med. 1954 Aug;47(8):617–621. doi: 10.1177/003591575404700801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. CATHALA H. P., POCIDALO J. J. Sur les effets de l'injection dans les ventricules cérébraux du chien du chlorhydrate de diméthylaminopropyl-N-chloro-phénothiazine; action centrale de ce produit. C R Seances Soc Biol Fil. 1952 Nov;146(21-22):1709–1711. [PubMed] [Google Scholar]
  5. CHARATAN F. B., BARTLETT N. G. The effect of chlorpromazine (largactil) on glucose tolerance. J Ment Sci. 1955 Apr;101(423):351–353. doi: 10.1192/bjp.101.423.351. [DOI] [PubMed] [Google Scholar]
  6. COSNIER J., DROUIN M. Contribution à l'étude du métabolisme hépatique du rat blanc neuroplégie. Bull Mens Soc Med Mil Fr. 1954 Jul;48(7):185–188. [PubMed] [Google Scholar]
  7. COURVOISIER S., FOURNEL J., DUCROT R., KOLSKY M., KOETSCHET P. Propriétés pharmacodynamiques du chlorhydrate de chloro-3-(diméthylamino-3'-propyl)-10-phénothiazine (4,560 R.P.); étude expérimentale d'un nouveau corps utilisé dans l'anesthésie potentialisée et dans l'hibernation artificielle. Arch Int Pharmacodyn Ther. 1953 Jan;92(3-4):305–361. [PubMed] [Google Scholar]
  8. DASGUPTA S. R., WERNER G. Inhibition of hypothalamic, medullary and reflex vasomotor responses by chlorpromazine. Br J Pharmacol Chemother. 1954 Dec;9(4):389–391. doi: 10.1111/j.1476-5381.1954.tb00850.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. EDGE N. D. The pharmacological differentiation of promethazine hydrochloride (phenergan) from iso-promethazine hydrochloride. Arch Int Pharmacodyn Ther. 1953 Sep 15;95(3-4):428–436. [PubMed] [Google Scholar]
  10. FOSTER C. A., O'MULLANE E. J., GASKELL P., CHURCHILL-DAVIDSON H. C. Chlorpromazine: a study of its action on the circulation in man. Lancet. 1954 Sep 25;267(6839):614–617. doi: 10.1016/s0140-6736(54)90400-6. [DOI] [PubMed] [Google Scholar]
  11. GIAJA J., MARKOVIC-GIAJA L. La chlorpromazine et la thermorégulation. C R Seances Soc Biol Fil. 1954 May;148(9-10):842–844. [PubMed] [Google Scholar]
  12. HALL R. A., PARKS M. W. The effect of drugs upon neuromuscular transmission in the guinea-pig. J Physiol. 1953 Nov 28;122(2):274–281. doi: 10.1113/jphysiol.1953.sp004998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. HALPERN B. N., LIAKOPOULOS P. Action comparée de la prométhazine et de la chlorpromazine sur la température chez le rat et le cobaye. C R Seances Soc Biol Fil. 1954 Jun;148(11-12):955–959. [PubMed] [Google Scholar]
  14. HIEBEL G., BONVALLET M., DELL P. Action de la chlorpromazine (Largactil 45 60 RP) au niveau du système nerveux central. Sem Hop. 1954 Jun 6;30(37):2346–2353. [PubMed] [Google Scholar]
  15. HOLZBAUER M., VOGT M. The action of chlorpromazine on diencephalic sympathetic activity and on the release of adrenocorticotrophic hormone. Br J Pharmacol Chemother. 1954 Dec;9(4):402–407. doi: 10.1111/j.1476-5381.1954.tb00852.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. HUIDOBRO F. Some pharmacological properties of chloro-3(dimethylamine-3' propyl) 10-phenothiazine or 4.560 R.P. Arch Int Pharmacodyn Ther. 1954 Jul 1;98(3):308–319. [PubMed] [Google Scholar]
  17. Hajdu I., McDowall R. J. The dependence of neuromuscular transmission on glucose. J Physiol. 1949 Jun 15;108(4):502–507. [PMC free article] [PubMed] [Google Scholar]
  18. KAHAN J. A rapid photometric method for the determination of glycogen. Arch Biochem Biophys. 1953 Dec;47(2):408–418. doi: 10.1016/0003-9861(53)90477-9. [DOI] [PubMed] [Google Scholar]
  19. KOPERA J., ARMITAGE A. K. Comparison of some pharmacological properties of chlorpromazine, promethazine, and pethidine. Br J Pharmacol Chemother. 1954 Dec;9(4):392–401. doi: 10.1111/j.1476-5381.1954.tb00851.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. LANCASTER N. P., JONES D. H. Chlorpromazine and insulin in psychiatry. Br Med J. 1954 Sep 4;2(4887):565–567. doi: 10.1136/bmj.2.4887.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. LONGO V. G., VON BERGER G. P., BOVET D. Action of nicotine and of the "ganglioplegiques centraux" on the electrical activity of the brain. J Pharmacol Exp Ther. 1954 Jul;111(3):349–359. [PubMed] [Google Scholar]
  22. MERIVALE W. H., HUNTER R. A. Abnormal glucose-tolerance tests in patients treated with sedative drugs. Lancet. 1954 Nov 6;267(6845):939–942. doi: 10.1016/s0140-6736(54)92554-4. [DOI] [PubMed] [Google Scholar]
  23. SALZMAN N. P., MORAN N. C., BRODIE B. B. Identification and pharmacological properties of a major metabolite of chlorpromazine. Nature. 1955 Dec 10;176(4493):1122–1123. doi: 10.1038/1761122a0. [DOI] [PubMed] [Google Scholar]
  24. SCHALLEK W. A screening program for quinidine-like activity. Arch Int Pharmacodyn Ther. 1956 Feb 1;105(1-2):221–229. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES